- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Keytruda in India: Miracle Cancer Drug or Costly Crisis? | Current Affairs | Drishti IAS
GS Studio Foundation Course में एडमिशन के लिए दिए गए लिंक पर क्लिक करें-
हिंदी मीडियम: https://drishti.xyz/GS-Studio-Foundation-Online-Course-Hindi
English Medium: https://drishti.xyz/GS-Studio-Foundation-Online-Course-English
Hinglish Medium: https://drishti.xyz/gs-studio-foundation-online-course-Hinglish
GS Studio Foundation Course की अधिक जानकारी या काउंसलिंग के लिए लिंक पर क्लिक करें –
https://drishti.xyz/GS-Studio-Foundation-Course
*************************************************************************
Keytruda (pembrolizumab), developed by Merck & Co. and approved by the US Food and Drug Administration in 2014, is one of the world’s leading immunotherapy drugs used to treat cancers such as lung, cervical, breast, and kidney cancer by enabling the body’s immune system to attack cancer cells more effectively. In India, however, its high cost—over ₹1.5 lakh per vial—has made it inaccessible for many patients, even as the country’s cancer burden continues to rise. An investigation by The Indian Express in collaboration with International Consortium of Investigative Journalists has revealed a growing counterfeit market for Keytruda, driven by affordability issues, standardized high dosing, and serious loopholes within hospital systems, including alleged insider involvement. While immunotherapy offers a more targeted approach compared to chemotherapy and radiation and has shown remarkable results even in advanced cancers, challenges related to pricing, access, and regulation remain critical in India’s healthcare system. With the drug’s patent expected to expire in 2028, the arrival of cheaper alternatives may improve accessibility, but until then, ensuring genuine supply and equitable access remains a major concern.
*************************************************************************
महत्त्वपूर्ण प्लेलिस्ट:
1. Drishtikon By Dr. Vikas Divyakirti:
https://drishti.xyz/Drishtikon-by-Dr-Vikas-Divyakirti
2. Videos by Dr. Vikas Divyakriti:
https://drishti.xyz/Videos-DrVikasDivyakirti-Playlist-YT
3. Concept Talk- By Dr. Vikas Divyakirti:
https://drishti.xyz/Concepttalk-DrVikasDivyakirti-Playlist-YT
4. NCERT Foundation Series:
https://drishti.xyz/NCERT-Foundation-Series-Hindi
5. How to Prepare Optional:
https://drishti.xyz/How-to-Prepare-Optional-Hindi
6. Optional Subject Demo Classes:
https://drishti.xyz/Optional-Subject-Demo-Classes
7. Daily Current News:
https://drishti.xyz/Daily-Current-News
8. Simplified Videos:
https://drishti.xyz/Simplified
9. Drishti IAS Special:
https://drishti.xyz/Drishti-IAS-Special
10. Duniya Is Hafte:
https://drishti.xyz/Duniya-Is-Hafte-DIH
11. Topper’s Success Stories:
https://drishti.xyz/Toppers-Success-Stories
12. UPSC Prelims PYQ Analysis:
https://drishti.xyz/UPSC-Prelims-PYQ-Analysis-Hindi
13. UPSC Mock Interview 2024:
https://drishti.xyz/UPSC-2024-Mock-Interview-Hindi-Medium
14. IAS Toppers Talk 2024:
https://drishti.xyz/Toppers-Talk-2024
15. IAS Toppers’ Seminar:
https://drishti.xyz/IAS-Toppers-Seminar
16. IAS Toppers’ Strategy:
https://drishti.xyz/IAS-Toppers-Strategy
*************************************************************************
हमारे प्रमुख कोर्सेज़:
1. GS Foundation Courses:
https://drishti.xyz/GS-foundation-Online-Courses
2. GS Studio Foundation Course (Hindi):
https://drishti.xyz/GS-Studio-Foundation-Online-Course-Hindi
3. GS Studio Foundation Course (Hinglish):
https://drishti.xyz/gs-studio-foundation-online-course-Hinglish
4. GS Studio Foundation Course (English):
https://drishti.xyz/GS-Studio-Foundation-Online-Course-English
5. NCERT Online Courses:
https://drishti.xyz/NCERT-Online-Courses
6. UPSC Optional Subjects Online Courses:
https://drishti.xyz/UPSC-Optional-Subjects-Online-Courses
7. IAS Prelims 2026 Online Courses:
https://drishti.xyz/IAS-Prelims-2026-Online-Courses
8. IAS Mains 2026 Online Courses:
https://drishti.xyz/IAS-Mains-2026-Online-Courses
9. Current Affairs (Prelims + Mains) IAS 2026 Online Courses:
https://drishti.xyz/UPSC-Current-Affairs-P-M-Online-Courses
10. UPSC Prelims 2026 Test Series:
https://drishti.xyz/IAS-Prelims-2026-Test-Series
11. UPSC Mains 2026 Test Series:
https://drishti.xyz/IAS-Mains-2026-Test-Series
12. EPFO Online Course:
https://drishti.xyz/UPSC-EPFO-Online-Courses
13. CAPF Online Courses:
https://drishti.xyz/CAPF-Online-Courses
*************************************************************************
Download Drishti Learning App Now:
iOS:
https://drishti.xyz/DLA-IOS
Android:
https://drishti.xyz/DLA-Android
Windows:
https://drishti.xyz/DLA-Windows
*************************************************************************
Follow Us on Social Media:
https://drishti.xyz/SocialMedia-YT
#Keytruda #CancerTreatment #Immunotherapy #CancerInIndia #HealthcareCrisis #BigPharma #MedicalNews #Oncology #ICIJ #IndianExpress #HealthPolicy #CancerAwareness #PharmaIndustry #BlackMarket #HealthcareIndia
#UPSCPreparation | #CivilServicesExam | #IASPreparation | #UPSC2026 | #UPSC
Видео Keytruda in India: Miracle Cancer Drug or Costly Crisis? | Current Affairs | Drishti IAS канала Drishti IAS
हिंदी मीडियम: https://drishti.xyz/GS-Studio-Foundation-Online-Course-Hindi
English Medium: https://drishti.xyz/GS-Studio-Foundation-Online-Course-English
Hinglish Medium: https://drishti.xyz/gs-studio-foundation-online-course-Hinglish
GS Studio Foundation Course की अधिक जानकारी या काउंसलिंग के लिए लिंक पर क्लिक करें –
https://drishti.xyz/GS-Studio-Foundation-Course
*************************************************************************
Keytruda (pembrolizumab), developed by Merck & Co. and approved by the US Food and Drug Administration in 2014, is one of the world’s leading immunotherapy drugs used to treat cancers such as lung, cervical, breast, and kidney cancer by enabling the body’s immune system to attack cancer cells more effectively. In India, however, its high cost—over ₹1.5 lakh per vial—has made it inaccessible for many patients, even as the country’s cancer burden continues to rise. An investigation by The Indian Express in collaboration with International Consortium of Investigative Journalists has revealed a growing counterfeit market for Keytruda, driven by affordability issues, standardized high dosing, and serious loopholes within hospital systems, including alleged insider involvement. While immunotherapy offers a more targeted approach compared to chemotherapy and radiation and has shown remarkable results even in advanced cancers, challenges related to pricing, access, and regulation remain critical in India’s healthcare system. With the drug’s patent expected to expire in 2028, the arrival of cheaper alternatives may improve accessibility, but until then, ensuring genuine supply and equitable access remains a major concern.
*************************************************************************
महत्त्वपूर्ण प्लेलिस्ट:
1. Drishtikon By Dr. Vikas Divyakirti:
https://drishti.xyz/Drishtikon-by-Dr-Vikas-Divyakirti
2. Videos by Dr. Vikas Divyakriti:
https://drishti.xyz/Videos-DrVikasDivyakirti-Playlist-YT
3. Concept Talk- By Dr. Vikas Divyakirti:
https://drishti.xyz/Concepttalk-DrVikasDivyakirti-Playlist-YT
4. NCERT Foundation Series:
https://drishti.xyz/NCERT-Foundation-Series-Hindi
5. How to Prepare Optional:
https://drishti.xyz/How-to-Prepare-Optional-Hindi
6. Optional Subject Demo Classes:
https://drishti.xyz/Optional-Subject-Demo-Classes
7. Daily Current News:
https://drishti.xyz/Daily-Current-News
8. Simplified Videos:
https://drishti.xyz/Simplified
9. Drishti IAS Special:
https://drishti.xyz/Drishti-IAS-Special
10. Duniya Is Hafte:
https://drishti.xyz/Duniya-Is-Hafte-DIH
11. Topper’s Success Stories:
https://drishti.xyz/Toppers-Success-Stories
12. UPSC Prelims PYQ Analysis:
https://drishti.xyz/UPSC-Prelims-PYQ-Analysis-Hindi
13. UPSC Mock Interview 2024:
https://drishti.xyz/UPSC-2024-Mock-Interview-Hindi-Medium
14. IAS Toppers Talk 2024:
https://drishti.xyz/Toppers-Talk-2024
15. IAS Toppers’ Seminar:
https://drishti.xyz/IAS-Toppers-Seminar
16. IAS Toppers’ Strategy:
https://drishti.xyz/IAS-Toppers-Strategy
*************************************************************************
हमारे प्रमुख कोर्सेज़:
1. GS Foundation Courses:
https://drishti.xyz/GS-foundation-Online-Courses
2. GS Studio Foundation Course (Hindi):
https://drishti.xyz/GS-Studio-Foundation-Online-Course-Hindi
3. GS Studio Foundation Course (Hinglish):
https://drishti.xyz/gs-studio-foundation-online-course-Hinglish
4. GS Studio Foundation Course (English):
https://drishti.xyz/GS-Studio-Foundation-Online-Course-English
5. NCERT Online Courses:
https://drishti.xyz/NCERT-Online-Courses
6. UPSC Optional Subjects Online Courses:
https://drishti.xyz/UPSC-Optional-Subjects-Online-Courses
7. IAS Prelims 2026 Online Courses:
https://drishti.xyz/IAS-Prelims-2026-Online-Courses
8. IAS Mains 2026 Online Courses:
https://drishti.xyz/IAS-Mains-2026-Online-Courses
9. Current Affairs (Prelims + Mains) IAS 2026 Online Courses:
https://drishti.xyz/UPSC-Current-Affairs-P-M-Online-Courses
10. UPSC Prelims 2026 Test Series:
https://drishti.xyz/IAS-Prelims-2026-Test-Series
11. UPSC Mains 2026 Test Series:
https://drishti.xyz/IAS-Mains-2026-Test-Series
12. EPFO Online Course:
https://drishti.xyz/UPSC-EPFO-Online-Courses
13. CAPF Online Courses:
https://drishti.xyz/CAPF-Online-Courses
*************************************************************************
Download Drishti Learning App Now:
iOS:
https://drishti.xyz/DLA-IOS
Android:
https://drishti.xyz/DLA-Android
Windows:
https://drishti.xyz/DLA-Windows
*************************************************************************
Follow Us on Social Media:
https://drishti.xyz/SocialMedia-YT
#Keytruda #CancerTreatment #Immunotherapy #CancerInIndia #HealthcareCrisis #BigPharma #MedicalNews #Oncology #ICIJ #IndianExpress #HealthPolicy #CancerAwareness #PharmaIndustry #BlackMarket #HealthcareIndia
#UPSCPreparation | #CivilServicesExam | #IASPreparation | #UPSC2026 | #UPSC
Видео Keytruda in India: Miracle Cancer Drug or Costly Crisis? | Current Affairs | Drishti IAS канала Drishti IAS
Keytruda pembrolizumab cancer drug India immunotherapy explained Merck MSD cancer treatment cost India black market medicine India fake cancer drugs oncology drugs PD-1 inhibitors checkpoint inhibitors cancer awareness India Indian Express investigation ICIJ investigation healthcare crisis India expensive medicines India cancer immunotherapy India pharma industry news cancer policy India drug pricing India
Комментарии отсутствуют
Информация о видео
14 апреля 2026 г. 13:35:00
00:16:42
Другие видео канала





















